BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29188179)

  • 1. Development of a high efficiency integration system and promoter library for rapid modification of
    Elmore JR; Furches A; Wolff GN; Gorday K; Guss AM
    Metab Eng Commun; 2017 Dec; 5():1-8. PubMed ID: 29188179
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic tools for reliable gene expression and recombineering in Pseudomonas putida.
    Cook TB; Rand JM; Nurani W; Courtney DK; Liu SA; Pfleger BF
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):517-527. PubMed ID: 29299733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of T7-Like Expression System in
    Liang T; Sun J; Ju S; Su S; Yang L; Wu J
    Front Chem; 2021; 9():664967. PubMed ID: 34336782
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of ssDNA recombineering and CRISPR-Cas9 for Pseudomonas putida KT2440 genome editing.
    Wu Z; Chen Z; Gao X; Li J; Shang G
    Appl Microbiol Biotechnol; 2019 Mar; 103(6):2783-2795. PubMed ID: 30762073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of genetic tools for heterologous protein expression in a pentose-utilizing environmental isolate of Pseudomonas putida.
    Gauttam R; Eng T; Zhao Z; Ul Ain Rana Q; Simmons BA; Yoshikuni Y; Mukhopadhyay A; Singer SW
    Microb Biotechnol; 2023 Mar; 16(3):645-661. PubMed ID: 36691869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas 2.0: genetic upgrading of P. putida KT2440 as an enhanced host for heterologous gene expression.
    Martínez-García E; Nikel PI; Aparicio T; de Lorenzo V
    Microb Cell Fact; 2014 Nov; 13():159. PubMed ID: 25384394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markerless gene knockout and integration to express heterologous biosynthetic gene clusters in Pseudomonas putida.
    Choi KR; Cho JS; Cho IJ; Park D; Lee SY
    Metab Eng; 2018 May; 47():463-474. PubMed ID: 29751103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved terephthalic acid production from p-xylene using metabolically engineered Pseudomonas putida.
    Luo ZW; Choi KR; Lee SY
    Metab Eng; 2023 Mar; 76():75-86. PubMed ID: 36693471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an efficient pathway construction strategy for rapid evolution of the biodegradation capacity of Pseudomonas putida KT2440 and its application in bioremediation.
    Zhao Y; Che Y; Zhang F; Wang J; Gao W; Zhang T; Yang C
    Sci Total Environ; 2021 Mar; 761():143239. PubMed ID: 33158512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Optimization of a Heterologous Pathway for Protocatechuate Catabolism in Escherichia coli Enables Bioconversion of Model Aromatic Compounds.
    Clarkson SM; Giannone RJ; Kridelbaugh DM; Elkins JG; Guss AM; Michener JK
    Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28733280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocols for RecET-based markerless gene knockout and integration to express heterologous biosynthetic gene clusters in Pseudomonas putida.
    Choi KR; Lee SY
    Microb Biotechnol; 2020 Jan; 13(1):199-209. PubMed ID: 30761747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered
    Peabody GL; Elmore JR; Martinez-Baird J; Guss AM
    Biotechnol Biofuels; 2019; 12():295. PubMed ID: 31890023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome reduction boosts heterologous gene expression in Pseudomonas putida.
    Lieder S; Nikel PI; de Lorenzo V; Takors R
    Microb Cell Fact; 2015 Feb; 14():23. PubMed ID: 25890048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Escherichia coli rhamnose promoter rhaP(BAD) is in Pseudomonas putida KT2440 independent of Crp-cAMP activation.
    Jeske M; Altenbuchner J
    Appl Microbiol Biotechnol; 2010 Feb; 85(6):1923-33. PubMed ID: 19789867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tn7-Based Device for Calibrated Heterologous Gene Expression in Pseudomonas putida.
    Zobel S; Benedetti I; Eisenbach L; de Lorenzo V; Wierckx N; Blank LM
    ACS Synth Biol; 2015 Dec; 4(12):1341-51. PubMed ID: 26133359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm as a production platform for heterologous production of rhamnolipids by the non-pathogenic strain Pseudomonas putida KT2440.
    Wigneswaran V; Nielsen KF; Sternberg C; Jensen PR; Folkesson A; Jelsbak L
    Microb Cell Fact; 2016 Oct; 15(1):181. PubMed ID: 27776509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chromosomal insertion loci in the Pseudomonas putida KT2440 genome for predictable biosystems design.
    Chaves JE; Wilton R; Gao Y; Munoz NM; Burnet MC; Schmitz Z; Rowan J; Burdick LH; Elmore J; Guss A; Close D; Magnuson JK; Burnum-Johnson KE; Michener JK
    Metab Eng Commun; 2020 Dec; 11():e00139. PubMed ID: 32775199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas putida KT2440 markerless gene deletion using a combination of λ Red recombineering and Cre/loxP site-specific recombination.
    Luo X; Yang Y; Ling W; Zhuang H; Li Q; Shang G
    FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26802072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a
    Wang H; Li J; Jewett MC
    Synth Biol (Oxf); 2018; 3(1):ysy003. PubMed ID: 32995512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing and transcriptional repression in Pseudomonas putida KT2440 via the type II CRISPR system.
    Sun J; Wang Q; Jiang Y; Wen Z; Yang L; Wu J; Yang S
    Microb Cell Fact; 2018 Mar; 17(1):41. PubMed ID: 29534717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.